Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New hernia mesh under study: will it reduce recurrence?

NCT ID NCT07289802

Disease control Sponsor: Swissmed Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Sep 18, 2026 · Updated 1 time

Summary

This study looks at how safe and effective a new mesh (3DMax MID) is for fixing inguinal hernias. About 300 adults having routine hernia surgery will get this mesh and be followed for a year. The main goal is to see how often the hernia comes back, and they will also check for pain and other problems.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 300 people

The number the study aims to enrol. It can still change while the study runs.

Started

Feb 2026

Expected to finish

Apr 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Adult patients with primary unilateral or bilateral inguinal hernia undergoing elective laparoendoscopic (TAPP or TEP) repair with implantation of the 3DMax MID Anatomical Mesh in participating centers.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age 18 years or older * Primary unilateral or bilateral inguinal hernia * Scheduled for elective laparoendoscopic inguinal hernia repair (TAPP or TEP) * Considered suitable for general anesthesia and laparoendoscopic approach by the treating surgeon * 3DMax MID Anatomical Mesh planned for use as part of routine clinical care * Ability and willingness to provide written informed consent Exclusion Criteria: * Age below 18 years * Emergency surgery (e.g. incarcerated or strangulated hernia requiring urgent intervention) * Contaminated or potentially contaminated surgical field * Recurrent inguinal hernia in the same groin (previous repair with mesh or suture) * Concomitant procedures or clinical situations in which the surgeon decides that a different mesh concept or technique is required * Inability or unwillingness to comply with follow-up schedule (e.g. lack of telephone contact, severe cognitive impairment)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hernia, inguinal are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Hernia Hernia, Inguinal Recurrence

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Hernia, inguinal

Contacts and locations

Locations

  • Swissmed Hospital

    Gdansk, 80-280, Poland

More trials for these conditions

Other studies related to the condition(s) this trial covers.